Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ... |
From inside the book
Results 1-5 of 68
Page 11648
... continue to remain so under current Departmental practices . Now , with respect to the MAC proposal specifically , Mr. Chair- man- we have three parts to it . The first is multiple source drugs , and it would , as I said , limit the ...
... continue to remain so under current Departmental practices . Now , with respect to the MAC proposal specifically , Mr. Chair- man- we have three parts to it . The first is multiple source drugs , and it would , as I said , limit the ...
Page 11649
... continuing supply of that drug . To assure access by physicians to any needed drug , the MAC limit would be waived when a prescriber certified in writing the necessity of a higher price product . And to assure that the MAC ceiling does ...
... continuing supply of that drug . To assure access by physicians to any needed drug , the MAC limit would be waived when a prescriber certified in writing the necessity of a higher price product . And to assure that the MAC ceiling does ...
Page 11651
... continue . Remarkable things have been developed by the private drug indus- try by this research , and we want it to continue , and we do not believe that the new regulation really should interfere with it . Some critics of the proposal ...
... continue . Remarkable things have been developed by the private drug indus- try by this research , and we want it to continue , and we do not believe that the new regulation really should interfere with it . Some critics of the proposal ...
Page 11660
... continues to be raised respecting assurance of comparability of drugs ? And Dr. Edwards answered : Mr. Chairman , I have said from the very beginining that I have thought that bioavailability or equivalency as it relates to our pricing ...
... continues to be raised respecting assurance of comparability of drugs ? And Dr. Edwards answered : Mr. Chairman , I have said from the very beginining that I have thought that bioavailability or equivalency as it relates to our pricing ...
Page 11672
... continue in such programs . If equitable revisions in the proposed implementation of the MAC policy are not forthcoming , APhA can only project that pharmacy participation will be further reduced to a level which will emasculate the ...
... continue in such programs . If equitable revisions in the proposed implementation of the MAC policy are not forthcoming , APhA can only project that pharmacy participation will be further reduced to a level which will emasculate the ...
Other editions - View all
Common terms and phrases
actual acquisition cost agencies antisubstitution laws APhA average wholesale price bioavailability bioequivalence brand name central CHAIRMAN competitive Defense develop Digoxin dispensing Drug Administration drug product Drug Research Board effective erythromycin established Food and Drug formulary Gaylord Nelson GORDON Government Government-wide hospital implementation inspection Interagency Labs local purchases MAC price MAC program MAC regulations Manufacturing Practices Maximum Allowable Cost Medicaid MEDICAL AND NONPERISHABLE medical items Medicare meeting ment MICHELOTTI patient percent Pharmaceutical pharmacists pharmacy physician PITTMAN prednisone prescribed present problems procurement professional proposed regulations purchasing quality assurance quality assurance program recommendations reimbursement resolution responsibility savings SCHMIDT Secretary WEINBERGER selection Small Business Sorett specific standards statement STETLER subcommittee substitution laws Supply Management Committee Tablets task group therapeutic equivalence tion TRYGSTAD WHITWORTH
Popular passages
Page 12087 - Since many agencies, including the Food and Drug Administration in the Department of Health, Education and Welfare, in which the appellant was employed, have nothing to do with national security, the Act of 1950 has nothing to do with them. The authorization to bring "other...
Page 12159 - Register, to be In the public interest in connection with the performance of duties imposed on that agency by law.
Page 11700 - I AM PLEASED TO BE HERE TODAY AND TO HAVE THE OPPORTUNITY TO ASK QUESTIONS OF SECRETARY JACKSON.
Page 12328 - Engineering before the Subcommittee on Health of the Senate Committee on Labor and Public Welfare, 94th Cong., 1st Sess.
Page 12055 - The hearing need not be conducted according to technical rules relating to evidence and witnesses. Any relevant evidence shall be admitted if it is the sort of evidence on which responsible persons are accustomed to rely in the conduct of serious affairs, regardless of the existence of any common law or statutory rule which might make improper the admission of such evidence over objection in civil actions.
Page 11663 - OF THE SELECT COMMITTEE ON SMALL BUSINESS, Washington, DC The subcommittee met, pursuant to notice, at 10 am, in room 2221.
Page 11925 - Action is pleased to have the opportunity to present its views on the $12.7 billion supplemental appropriation for America's efforts in Vietnam.
Page 11732 - STATEMENT OF ALEXANDER M. SCHMIDT, MD, COMMISSIONER, FOOD AND DRUG ADMINISTRATION; ACCOMPANIED BY J. RICHARD GROUT, MD, DIRECTOR, BUREAU OF DRUGS; PETER BARTON »HUTT, ASSISTANT GENERAL COUNSEL; LLOYD B. TEPPER, MD, ASSOCIATE COMMISSIONER FOR SCIENCE; BARRETT SCOVILLE, MD, ACTING DIRECTOR OF THE DIVISION OF BUREAU OF NEUROt PHARMACOLOGICAL PROJECTS; AND ROBERT WETHERELL, DIRECTOR, OFFICE OF LEGISLATIVE SERVICES Dr.
Page 12055 - substantial evidence" means : Evidence consisting of adequate and well controlled investigations, including clinical investigations by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling...
Page 12054 - The means employed shall be such as to allow, to the extent practicable, eligible persons to secure health care in the same manner employed by the public generally, and without discrimination or segregation based purely on their economic disability.